BTAI vs CLOV · rev $2.3M vs rev $1.37B
BioXcel Therapeutics Inc (BTAI) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BTAI revenue for 2024-12-31 was $2.3M. Net income was -$59.6M. Revenue was up 64.2% from 2023-12-31 to 2024-12-31. BTAI currently screens at market cap $36.1M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BTAI currently screens at market cap $36.1M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BTAI and CLOV stock pages for the full models.
Not investment advice.